Mefloquine and malaria prophylaxis
Relevant BNF section: 5.4.1
In the UK, mefloquine (Lariam - Roche) has been marketed since 1990 for both malaria prophylaxis and for acute treatment of falciparum malaria. In 1991, we concluded that prophylaxis with mefloquine was appropriate for those travelling to areas where strains of Plasmodium falciparum resistant to chloroquine and proguanil are common.1 Since then, UK recommendations have changed several times. Recently, mefloquine's use as a prophylactic has been questioned because of reports of neuropsychiatric unwanted effects. This article discusses the place of mefloquine in malaria prophylaxis in light of these concerns.
CiteULike 
Complore 
Connotea 
Del.icio.us 
Digg 
Reddit 
Technorati What's this?
This article has been cited by other articles:
-
Croft, A.
(2000). Extracts from "Clinical Evidence": Malaria: prevention in travellers. BMJ
321: 154-160
[Abstract] [Full Text] -
Behrens, R. H, Erny, S., Maradit, H., Houston, S., Keystone, J. S, Kain, K. C, Croft, A., Garner, P.
(1998). Mefloquine to prevent malaria. BMJ
316: 1980a-1980
[Full Text]
- Full Text
- Full Text (PDF)
- Submit a response
- Alert me when this article is cited
- Alert me when eLetters are posted
- Alert me if a correction is posted
Services
- Email this link to a friend
- Similar articles in this journal
- Similar articles in PubMed
- Add article to my folders
- Download to citation manager
- Request Permissions
Citing Articles
Google Scholar
PubMed
Topic Collections
Bookmark with
Register for email alerts
Don't forget to sign up for content alerts so you keep up to date with all the articles as they are published.
Coming soon!
The DTB archive back to 1962, volume 1, issue 1 will soon be available.
